New Study Showing Increased Risks Associated with Aggressive Insulin Therapy

Tmerchant's picture
A new study led by interventional cardiologists at the LifeBridge Health Cardiovascular Institute reveals that older patients (over age 75) with type II diabetes and heart disease have a higher mortality rate when they are treated with insulin provision therapy (IP) compared to insulin sensitizing therapy (IS).
Syndicate content